Candel Therapeutics (CADL)

• Market cap: $301M
• 1 day: 1.67%
• 5 days: -2.83%
• 1 month: 1.67%
• 3 months: -19.97%
• 6 months: 10.46%
• Year to date: -38.93%
• 1 year: -0.36%
• 5 years: -21.57%
• 10 years: -21.57%
• Sector: Healthcare
• Industry: Biotechnology

About: Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Employees: 38